CDK4 and neoplasm: Evidence from breast cancer mouse models suggests that Cyclin D1, and CDK4 and CDK6 activation contribute to suppressing senescence, as Cyclin D1 ablation in these models after tumor formation led to an onset of senescence in the isolated tumor cells, as did treatment with a CDK4 and CDK6 inhibitor [6].